Pharmacist Diabetes | Weight Management On-Demand 1 credit hour

What are the effects of subcutaneous semaglutide added to high daily doses of insulin in patients with type 2 diabetes? Take this course to learn more!

Available in Subscription

This course is included in the following subscription:

Pharmacist CE Subscription

Pharmacist CE Subscription

Renewed Annually
$99.00 / year

Learning Objectives

Upon successful completion of this application-based course, participants should be able to:
1. List the benefits of decreasing the total daily dose of insulin.
2. Describe the patient population who may benefit most from the addition of semaglutide to high total daily dose insulin therapy.
3. Review the strengths, limitations, and results of the semaglutide trial.
4. Discuss the role of semaglutide as treatment in type 2 diabetes mellitus patients with a high total daily dose of insulin.
5. Apply the results of the semaglutide trial to a patient case.

Faculty

Emily Van Klompenburg, PharmD, BACAP

Assistant Professor
South Dakota State University
College of Pharmacy and Allied Health Professions

Disclosures:

Emily Van Klompenburg has no relevant financial relationships with ineligible companies to disclose.

Course Details